Skip to main content

Advertisement

Log in

[18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Armstrong MJ, Litvan I, Lang AE et al (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80:496–503. doi:10.1212/WNL.0b013e31827f0fd1

    Article  PubMed  PubMed Central  Google Scholar 

  2. Chien DT, Bahri S, Szardenings AK et al (2013) Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. J Alzheimers Dis 34:457–468. doi:10.3233/JAD-122059

    CAS  PubMed  Google Scholar 

  3. Dickson DW, Bergeron C, Chin SS et al (2002) Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 61:935–946

    Article  CAS  PubMed  Google Scholar 

  4. Josephs KA, Whitwell JL, Ahmed Z et al (2008) Beta-amyloid burden is not associated with rates of brain atrophy. Ann Neurol 63:204–212. doi:10.1002/ana.21223

    Article  PubMed  PubMed Central  Google Scholar 

  5. Josephs KA, Duffy JR, Strand EA et al (2012) Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain 135:1522–1536. doi:10.1093/brain/aws032

    Article  PubMed  PubMed Central  Google Scholar 

  6. Lowe VJ, Curran G, Fang P et al (2016) An autoradiographic evaluation of AV-1451 Tau PET in dementia. Acta Neuropathol Commun 4:58. doi:10.1186/s40478-016-0315-6

    Article  PubMed  PubMed Central  Google Scholar 

  7. Marquie M, Normandin MD, Vanderburg CR et al (2015) Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann Neurol 78:787–800. doi:10.1002/ana.24517

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Sander K, Lashley T, Gami P et al (2016) Characterization of tau positron emission tomography tracer [F]AV-1451 binding to postmortem tissue in Alzheimer’s disease, primary tauopathies, and other dementias. Alzheimers Dement. doi:10.1016/j.jalz.2016.01.003

    PubMed  Google Scholar 

  9. Smith R, Puschmann A, Scholl M et al (2016) 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers. Brain 139:2372–2379. doi:10.1093/brain/aww163

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This study was supported by NIH Grants R01-NS89757 (PI, Josephs) and R01-DC12519 (PI, Whitwell).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Keith A. Josephs.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 35 kb)

Supplementary material 2 (DOCX 26 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Josephs, K.A., Whitwell, J.L., Tacik, P. et al. [18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration. Acta Neuropathol 132, 931–933 (2016). https://doi.org/10.1007/s00401-016-1618-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-016-1618-1

Keywords

Navigation